Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbzena Regulatory News (ABZA)

  • There is currently no data for ABZA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

11 Jan 2016 14:14

RNS Number : 4751L
Abzena PLC
11 January 2016
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

ABZENA PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

IMPERIAL INNOVATIONS GROUP PLC

4. Full name of shareholder(s)  (if different from 3.):iv

IMPERIAL INNOVATIONS BUSINESSES LLP

IMPERIAL INNOVATIONS LIMITED

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

11 DECEMBER 2015

6. Date on which issuer notified:

8 JANUARY 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

23%, 22%, 21%, 20%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

ORDINARY

22,953,452

22,953,452

27,120,102

27,120,102

19.9%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

27,120,102

19.9%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

William Rayner

General Counsel and Company Secretary

15. Contact telephone number:

020 3053 8859

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUAASRNAAAAAR
Date   Source Headline
11th Apr 20173:06 pmRNSDirector/PDMR Shareholding
7th Apr 20171:36 pmRNSGrant of options
5th Apr 20173:45 pmRNSResult of bookbuild
5th Apr 20177:00 amRNSProposed Placing of £25m
6th Mar 20177:00 amRNS'Abzena inside' product enters Phase II trial
3rd Mar 20177:00 amRNSPartner Halozyme to present poster at AACR
1st Mar 20177:00 amRNSMRC grant awarded to collaboration group
21st Feb 20177:01 amRNSAntibody manufacturing development agreement
21st Feb 20177:00 amRNSTrading and business update
8th Feb 20178:43 amEQSEdison issues outlook on Abzena
6th Feb 201710:55 amRNSTotal Voting Rights
31st Jan 201712:53 pmRNSHardman Research: ThioBridge deal update
24th Jan 20177:00 amRNSIssue of Equity
20th Jan 20177:00 amRNSThioBridge license agreement
9th Jan 20179:37 amRNSBlocklisting update
22nd Dec 20167:00 amRNSLicence agreement
13th Dec 20167:15 amRNSHardman Research: Opening new doors
30th Nov 20167:00 amRNSHalf year results
23rd Nov 20168:09 amRNS'Abzena inside' product study data to be presented
15th Nov 201612:42 pmRNSNotice of half year results
2nd Nov 20167:00 amRNSLicensed product candidate update
24th Oct 20167:00 amRNSSenior Executive Appointments
21st Oct 20167:00 amRNSLicensed product candidate update
22nd Sep 20169:30 amRNSLicensed product candidate update
19th Sep 20162:28 pmRNSChange of Nominated Adviser and Broker
14th Sep 20163:58 pmRNSEdison issues research update on Abzena (ABZA)
13th Sep 20163:41 pmRNSResult of AGM
13th Sep 20167:00 amRNSDirectorate Change
13th Sep 20167:00 amRNSAGM Business Update
16th Aug 201612:20 pmRNSDirector/PDMR Shareholding and Exercise of Options
9th Aug 20162:30 pmRNSNotice of AGM
28th Jul 201611:45 amRNSEdison issues research update on Abzena (ABZA)
25th Jul 20167:00 amRNSManufacturing agreement
14th Jul 201610:37 amRNSJoint venture with Baylor Research Institute
6th Jul 20163:58 pmRNSBlock Listing Update
27th Jun 20164:46 pmRNSDirector Dealings
24th Jun 20169:45 amRNSExercise of warrants
22nd Jun 201610:12 amRNSEdison issues research review on Abzena (ABZA)
15th Jun 20164:09 pmRNSAnnual Report and Accounts
14th Jun 20167:00 amRNSFull year results
26th May 20167:00 amRNSNotice of Results
5th Apr 20169:20 amRNSExercise of Employee Share Options
1st Apr 20169:48 amRNSExercise of Share Options and Director Dealings
16th Mar 20169:45 amRNSExercise of Employee Share Options
9th Mar 201612:47 pmRNSExercise of Employee Share Options
9th Mar 20167:00 amRNSBusiness update
8th Feb 20163:14 pmRNSExercise of employee share options
4th Feb 20162:33 pmRNSHolding(s) in Company
25th Jan 20167:00 amRNSSignificant licence deal for ThioBridgeT
18th Jan 20167:00 amRNSAntitope collaboration awarded European grant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.